pharmaceutical branding - · pdf filedupont ferring fresenius galderma ... following pages and...

The power of creativitywww.originbranding.com

Pharmaceutical Branding

2012

Abbott ProductsAllergan

Alliance PharmaAstellas

AstraZenecaAxis-Shield

BaxterBayer

BDBiotest

DuoCortDuPontFerring

FreseniusGalderma

GrünenthalGlaxoSmithKline

IntercytexIntervet

Janssen PharmaceuticaJohnson & Johnson

LundbeckMerck

Merck SeronoNovartis

Novo NordiskNycomed

Orion PharmaProcter & Gamble

PfizerPhilips Medical

RocheShire

SanofiUCB

We are an independent, boutique agency passionately focused on developing pharmaceutical brands. For over 15 years we have delivered outstanding branding solutions for our clients from our offices in Surrey, UK and Birmingham, Michigan.

Developing a brand identity that communicates your brand message, ensures differentiation and clears the relevant trademark screening and regulatory checks can be a challenging task.

Our proven branding process has been built on creativity, flexibility and a strong understanding of all the issues and challenges surrounding the registration of a new identity, irrespective of geographical or business area.

Many examples of our naming, design and research projects are presented in the following pages and additional examples of our work in the pharmaceutical and other industries can be found in our website.

We look forward to speaking with you about your branding challenges!

DuoCort - Plenadren

DuoCort’s new treatment for Addison’s disease, a rare and life threatening adrenal insufficiency disease. Instantly meaningful and easily communicated, Plenadren is derived from ‘plenty’ and ‘adrenal’ and conveys confidence, re-assurance and increased control.

Janssen Pharmaceutica - Xeplion

Janssen Pharmaceutica’s once monthly, long-acting injectable, antipsychotic for the treatment of schizophrenia. Xeplion is a dynamic, impactful, strong and modern sounding name reflecting the innovative approach to the treatment.




BaxterBayer

BDBiotest

DuoCort

DuPontFerring

FreseniusGalderma


IntercytexIntervet

Janssen Pharmaceutica

Johnson & JohnsonLundbeck

MerckMerck Serono

NovartisNovo Nordisk

NycomedOrion Pharma

Procter & GamblePfizer

Philips MedicalRocheShire

SanofiUCB

Bayer and Johnson & Johnson - Xarelto

Bayer and Johnson & Johnson’s oral anti-coagulant to prevent blood clots after orthopaedic surgery. Xarelto is a ground breaking new factor Xa inhibitor. The name is modern, impactful and resonates with prescribers and patients alike, characteristics that re-enforce the key brand message.

Bayer - Levitra ODT

Origin created the Levitra brand name for Bayer and were later asked to create an innovative, added-value packaging for the new ODT formulation. We created a unique system that included a pull out tab containing key information for the patient. The blister pack is encased in a discreet matt black sleeve to create a luxurious and empowering user experience.




Baxter

Bayer

BDBiotest


FreseniusGalderma


IntercytexIntervet

Janssen Pharmaceutica

Johnson & Johnson

LundbeckMerck


Novo NordiskNycomed



RocheShire

SanofiUCB

FirmagonPackaging development for a hormonal therapy

for prostate cancer

Omnic WowtabVisual identity for an orodispersible

urology formulationfor Astellas

ReplagalAn enzyme replacement

therapy for patients with Fabry disease

ElapraseIndicated for patients

with Hunter syndrome

PosidormA new brand of

melatonin that promotes better sleep in a variety

of sleep disorders

FlomaxtraBrand Identity for a

BPH (Benign Prostatic Hyperplasia) treatment

Abbott (Solvay) - Creon

Origin consolidated a variety of differing brand logos to create a single global presence. This new identity capitalises on Solvay’s expertise and Creon’s patented minimicrosphere technology which allows appropriate delivery of enzymes into the body.

Shire - Elaprase

Elaprase is indicated for patients with Hunter syndrome. A global set of packaging including over 500 pieces of artwork was created for use across all countries applying the latest regulatory information.

Abbott Products

AllerganAlliance Pharma

AstellasAstraZenecaAxis-Shield

BaxterBayer

BDBiotest


FreseniusGalderma


IntercytexIntervet

Janssen PharmaceuticaJohnson & Johnson

LundbeckMerck


Novo NordiskNycomed



Roche

Shire

SanofiUCB

NovoPen EchoInsulin pen from

Novo Nordisk designed for children with diabetes

ACCU-CHEK InformRoche Diagnostics’ fully

integrated portable blood glucose testing system

IsprelorA name and logo of

misoprostol for Alliance Pharmaceuticals

NexivaBD Nexiva Closed IV

Catheter System

OmnifuseInfusion syringe pump

system for Smiths Industries

AfinionA point of care

multiparameter analyser system for Axis-Shield

AfinitorNovartis’ treatment for

renal cell carcinoma

CaprelsaAstraZeneca’s kinase

inhibitor indicated forthyroid cancer

SelincroLundbeck’s treatment for

alcohol dependency

LevitraErectile dysfunction

drug, co-marketed byBayer and GSK

PrezistaHIV protease inhibitor

from Tibotec

ZutectraBiotest’s drug for the prevention of

hepatitis B after liver transplantation

Brand design

Symbol/logotype development

Packaging designIdentity guidelines

Pharmaceutical artwork

Brand naming

Brand name generationTagline/brand statementdevelopmentBrand naming architectureINN name generation

Brand market research

Brand equity/awareness studiesName validation

Linguistic screeningTrademark/legal pre-screening

Safety testingScriptability testing

Brand strategy

Strategic brand analysisPortfolio analysisBrand extension/positioningVisual brand evaluation

UK Office: Bridge House, 72 Bridge Road, East Molesey, Surrey KT8 9HF Tel: +44(0)20 8941 5811 US Office: 200 Elm Street, Birmingham, MI 48009 Tel: +1 248 723 7833

pharmaceutical branding - · pdf filedupont ferring fresenius galderma ... following pages and...

Documents